As of 2025-09-14, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (14.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1154.7%.
The range of the Relative Valuation is (14.50) - (14.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 13.8x | 13.6x |
| Forward P/E multiples | 12.5x - 13.0x | 12.8x |
| Fair Price | (14.50) - (14.07) | (14.24) |
| Upside | -1174.3% - -1142.3% | -1154.7% |
| Date | P/E |